S&P 500

6.040,53

-0,50%

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NYSE
Cencora Inc (COR)
Cencora Inc (COR) Notícias

COR

Cencora (COR)

Cencora Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NYSE:COR

1 2 3 4 5 6 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
31/01/2025	17:59	Edgar (US Regulatory)	Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NYSE:COR	Cencora Inc
23/01/2025	18:27	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NYSE:COR	Cencora Inc
23/01/2025	18:21	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NYSE:COR	Cencora Inc
23/01/2025	18:17	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NYSE:COR	Cencora Inc
22/01/2025	18:07	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:COR	Cencora Inc
13/01/2025	18:29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:COR	Cencora Inc
08/01/2025	09:30	Business Wire	Cencora Announces Date and Time for First Quarter Fiscal 2025 Earnings Release	NYSE:COR	Cencora Inc
02/01/2025	18:15	Business Wire	Cencora Completes Acquisition of Retina Consultants of America	NYSE:COR	Cencora Inc
20/12/2024	15:48	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:COR	Cencora Inc
09/12/2024	18:15	Business Wire	Cencora Closes $1.8 Billion Senior Notes Offering	NYSE:COR	Cencora Inc
04/12/2024	18:59	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NYSE:COR	Cencora Inc
03/12/2024	00:49	Business Wire	Cencora Prices $500 Million 4.625% Senior Notes Due 2027, $600 Million 4.850% Senior Notes Due 2029 and $700 Million 5.150% Senior Notes Due 2035	NYSE:COR	Cencora Inc
02/12/2024	19:01	Edgar (US Regulatory)	Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses	NYSE:COR	Cencora Inc
02/12/2024	10:18	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NYSE:COR	Cencora Inc
26/11/2024	18:30	Edgar (US Regulatory)	Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers	NYSE:COR	Cencora Inc
26/11/2024	16:45	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NYSE:COR	Cencora Inc
06/11/2024	08:35	Business Wire	Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results	NYSE:COR	Cencora Inc
06/11/2024	08:30	Business Wire	Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America	NYSE:COR	Cencora Inc
04/11/2024	10:30	Business Wire	Cencora Expands Enterprise Leadership Team with Two Senior Appointments	NYSE:COR	Cencora Inc
01/10/2024	17:06	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NYSE:COR	Cencora Inc
01/10/2024	08:30	Business Wire	Cencora Announces Date and Time for Fourth Quarter Fiscal 2024 Earnings Release	NYSE:COR	Cencora Inc
20/08/2024	17:05	Edgar (US Regulatory)	Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]	NYSE:COR	Cencora Inc
15/08/2024	08:30	Business Wire	Cencora Elects Frank Clyburn to Its Board of Directors	NYSE:COR	Cencora Inc
01/08/2024	19:17	Business Wire	Cencora Announces Common Share Repurchase From Walgreens Boots Alliance	NYSE:COR	Cencora Inc
01/08/2024	19:08	Business Wire	Walgreens Boots Alliance Sells Shares of Cencora for Approximately $1.1 Billion of Proceeds	NYSE:COR	Cencora Inc
31/07/2024	17:12	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NYSE:COR	Cencora Inc
31/07/2024	17:05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NYSE:COR	Cencora Inc
31/07/2024	07:30	Business Wire	Cencora Reports Fiscal 2024 Third Quarter Results	NYSE:COR	Cencora Inc
08/07/2024	09:35	GlobeNewswire Inc.	Outlook Therapeutics® Announces UK MHRA Marketing Authorization of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD	NYSE:COR	Cencora Inc
05/07/2024	17:15	Business Wire	Cencora Announces Date and Time for Third Quarter Fiscal 2024 Earnings Release	NYSE:COR	Cencora Inc